Publications by authors named "Bela Piko"

Claim this Profile
F
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies.
Yutaka Yamamoto, Hiroyasu Yamashiro, Andreas Schneeweiss, Volkmar Müller, Oleg Gluz

Breast Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer.
Gábor Rubovszky, Judit Kocsis, Katalin Boér, Nataliya Chilingirova, Magdolna Dank

Pathol Oncol Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oncodiabetology III. The relationship of antineoplastic therapies and carbohydrate metabolism].
Róbert János Bánhegyi, Blanka Veréb, Andrea Gazdag, Beatrix Rácz, Róbert Wagner

Orv Hetil· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
Gábor Rubovszky, Judit Kocsis, Katalin Boér, Nataliya Chilingirova, Magdolna Dank

Pathol Oncol Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Rare, but existing clinical entity - the neuroendocrine cancer of the bladder].
Béla Pikó, Anita Kis, Ibolya Laczó, Tibor Mészáros, Ali Bassam

Magy Onkol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
["The phlebotomist" - venous punction and venous access obtaining in the department of oncology].
Anita Szabó, Erzsébet Csikósné Mácsok, Béla Pikó

Magy Onkol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Systemic treatment of breast cancer: professional guideline].
Zsolt Horváth, Katalin Boér, Magdolna Dank, Zsuzsanna Kahán, Judit Kocsis

Magy Onkol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Systemic therapy of breast cancer: practice guideline].
Zsolt Horváth, Katalin Boér, Magdolna Dank, Zsuzsanna Kahán, Judit Kocsis

Magy Onkol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective noninterventional study on the use of panitumumab monotherapy in patients with recurrent or progressive colorectal cancer: the VECTIS study.
Radek Lakomy, Wojciech Rogowski, Bela Piko, Zh Mihaylova, Eva Pritzova

Cancer Manag Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Fulvestrant (Faslodex®) for hormone sensitive breast cancer. A review].
Tamás Nagykálnai, László Landherr, Ibolya Laczó, Béla Pikó

Magy Onkol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line bevacizumab-paclitaxel in 220 patients with metastatic breast cancer: results from the AVAREG study.
Magdolna Dank, Laszlo Budi, Bela Piko, Laszlo Mangel, Jozsef Erfan

Anticancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Gastrointestinal locations of primary melanoma].
Arpád Rózsa, Erzsébet Mellár, Sándor Poczik, Róbert János Bánhegyi, Péter Soós

Magy Seb· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Use of angioneogenesis inhibitor monoclonal antibody following standard therapy in recurrent or progressive glioblastoma multiforme].
Béla Pikó, Ali Bassam, Krisztina Agnes Nagy, Enikõ Török, Rita Vághy

Magy Onkol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Detection of multiple colon and rectal tumors during diagnostic treatment and follow-up].
Béla Pikó, Pál Rahóty, Ildikó Krémer, János Zsilák, Enikõ Török

Magy Onkol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Thoughts about thromboembolic events prophylaxis in cancer patients].
Béla Pikó, Ildiko Maria Kremer, Pal Rahoty, Ali Bassam, Sándor Dimák

Magy Onkol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Extravasation of cytostatic drugs].
Béla Pikó, Klára Puskásné Szatmári, Ali Bassam, Margit Csiffári, Sándor Dimák

Magy Onkol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antidiabetic therapy--a new possibility in the complex therapy of cancer?].
Róbert János Bánhegyi, Paul Ovidiu Rus-Gal, Agnes Krisztina Nagy, Tibor Martyin, Róbert Wágner

Magy Onkol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmaceutical therapy of breast cancer].
István Láng, Zsuzsanna Kahán, Tamás Pintér, Magdolna Dank, Katalin Boér

Magy Onkol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lapatinib treatment-option in trastuzumab-resistant breast cancer].
Béla Pikó

Magy Onkol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Panitumumab-treatment of metastatic colorectal cancer].
Béla Pikó

Magy Onkol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Position statement of the Hungarian Radiotherapy and Oncology College on the insurance coverage of Vectibix (panitumumab)].
Béla Pikó,

Magy Onkol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Position statement of the Hungarian Radiotherapy and Oncology College on the insurance coverage of Ratiograstim (biocompatible filgrastim)].
Béla Pikó,

Magy Onkol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of tumor therapy-induced nausea and vomiting].
Béla Pikó, Ali Bassam

Magy Onkol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Position statement of the (Hungarian) College of Oncology and Radiotherapy regarding the financing of Tyverb (lapatinib) based on individual discretionary compassionate care].
Béla Pikó,

Magy Onkol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Position statement of the (Hungarian) College of Oncology and Radiotherapy regarding the health insurance reimbursement for Emend(aprepitant)].
Béla Pikó,

Magy Onkol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis